首页> 外文期刊>Reviews in Immunogenetics >Genetic and immunological basis of autoimmune diabetes in the NOD mouse
【24h】

Genetic and immunological basis of autoimmune diabetes in the NOD mouse

机译:NOD小鼠自身免疫性糖尿病的遗传和免疫学基础

获取原文
获取原文并翻译 | 示例
       

摘要

The non-obese diabetic (NOD) mouse is an animal model of human insulin-dependent diabetes mellitus (IDDM). Most NOD mice show insulitis at several weeks of age, and 60-90% of the female mice develop overt diabetes after 20-30 weeks of age. NOD mice share many features of human IDDM. As in human IDDM, the disease development in NOD mice is controlled by a number of disease susceptibility or resistant genes (Idds), including the major histocompatibility complex locus. Cumulative evidence suggests that Th1 CD4~+ T cells play a critical role in the autoimmune process leading to β cell destruction. In addition to CD4~+ T cells, CD8~+ cells and B cells also participate in the pathogenesis. There are several candidate antigens recognized by autoreactive T cells such as glutamic acid decarboxylase (GAD), insulin and heat shock protein (HSP) 60. Treatment by these antigens suppresses IDDM development in NOD mice, suggesting that they may initiate the autoimmune process of NOD mice.
机译:非肥胖糖尿病(NOD)小鼠是人类胰岛素依赖型糖尿病(IDDM)的动物模型。大多数NOD小鼠在几周龄时表现出肠炎,而60-90%的雌性小鼠在20-30周龄后出现明显的糖尿病。 NOD小鼠具有人类IDDM的许多功能。与人类IDDM一样,NOD小鼠的疾病发展受多种疾病的易感性或抗性基因(Idds)的控制,包括主要的组织相容性复合体基因座。累积证据表明,Th1 CD4〜+ T细胞在导致β细胞破坏的自身免疫过程中起关键作用。除CD4〜+ T细胞外,CD8〜+细胞和B细胞也参与发病。自身反应性T细胞可识别几种候选抗原,例如谷氨酸脱羧酶(GAD),胰岛素和热休克蛋白(HSP)60。用这些抗原进行治疗可抑制NOD小鼠的IDDM发育,表明它们可能启动NOD的自身免疫过程。老鼠。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号